Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by PoorOpinionon Mar 16, 2018 8:35am
143 Views
Post# 27725934

RE:People here should learn about forward looking statements

RE:People here should learn about forward looking statementsWell there's a touch of realism for the morning start, nicely said. Now everybody back to your dreaming and conspiracy theories.

HipFlex wrote: If something is written a presentations in a certain way - it doesn't indicate anything.  Words like "believe", "estimate", "anticipate", "plan", "predict", "may", "hope", "can", "will", "should", "expect", "intend", "is designed to", "with the intent", "potential" usually mean that it is an forward looking statement. There is something called continuity that is very important in the world of business. Managers manage in a way that reflects the continuity of business in the future. They don't write in the presentation: "If we get bad results we go bankrupt, but if we get good results we look for partners." They instead write it in a way that reflects continuity of business in the future and supports established plans. The company has a plan and a million things could go wrong with it. Instead of muddling upon the several paths, positive or negative, that the firm could face, they describe the strategy and the meaning that the company was established for. 

Let me reiterate: Topstone has the results, Antibe doesn't know the results, the stock market is always unpredictable so don't derive your own bullshit conspiracy theories about how the companies involved here know and leak stuff to the public. These guys are rarely in it for the money. They do what they love and love what they do and these drugs have sentimental value to the people involved. If this was all about money this whole project would've gone down long ago. 


Bullboard Posts